Public Profile

Novartis India Limited

Novartis India Limited, a subsidiary of the global healthcare leader Novartis AG, is headquartered in Mumbai, India. Established in 1947, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines, generics, and biosimilars. With a strong presence across major operational regions in India, Novartis India is dedicated to addressing unmet medical needs through its diverse portfolio. The company’s core products include patented pharmaceuticals in areas such as oncology, cardiology, and ophthalmology, distinguished by their cutting-edge research and development. Novartis India has consistently maintained a strong market position, recognised for its commitment to quality and patient-centric solutions. Notable achievements include numerous awards for innovation and excellence in healthcare, solidifying its reputation as a trusted name in the Indian pharmaceutical landscape.

DitchCarbon Score

How does Novartis India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

56

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Novartis India Limited's score of 56 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Novartis India Limited's reported carbon emissions

Novartis India Limited currently does not have publicly available emissions data for the most recent year, nor are there specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their carbon emissions performance or climate strategy. However, as part of the pharmaceutical industry, Novartis is expected to align with global sustainability trends and may engage in initiatives aimed at reducing their carbon footprint in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Novartis India Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Novartis India Limited is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Novartis India Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Solvay Pharma

FR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Hexagon Nutrition Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

GlaxoSmithKline Consumer Healthcare, Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Abbott India Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

AstraZeneca Pharma India Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

GlaxoSmithKline Pharmaceuticals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers